Transient expression of FOXP3 in human activated nonregulatory CD4 + T cells
Open accessThe DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Foxp3 plays a key role in CD4 + CD25 + T reg cell function in mice and represents a specific marker for these cells. Despite the strong association between FOXP3 expression and regulatory function in fresh human T cells, little is known about the dynamics of endogenous FOXP3 expression and its relation to the suppressive function in activated human T cells. Here, we addressed the dynamics of FOXP3 expression during human CD4 + T cell activation by plate‐bound anti‐CD3 Ab as well as the relationship between its expression and regulatory function at the single‐cell level. Our data show that FOXP3 is expressed in a high percentage of activated T cells after in vitro stimulation of human CD4 + CD25 – cells. FOXP3 expression is strongly associated with hyporesponsiveness of activated T cells, but is not directly correlated with their suppressive capabilities, as we demonstrate that it is also expressed in activated nonsuppressive T cells. However, in this nonsuppressive T cell population, FOXP3 expression is transient, while it is stably expressed in activated T cells that do display suppressive function, and in natural CD4 + CD25 ++ T reg cells. These data indicate that expression of endogenous FOXP3, in humans, is not sufficient to induce regulatory T cell activity or to identify T reg cells. See accompanying commentary http://dx.doi.org/10.1002/eji.200636929
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, stimulation with immobilized CD3 mAb is known to increase FoxP3 expression that is strongly associated with hypo-responsiveness by activated CD4+ T-cells and is not directly correlated with suppressive capability 37 . It is, therefore, likely that this is also the case with TGN1412 in the solid phase assay since both TGN1412 and muromonab-CD3 stimulate a similar cytokine response.”
From Severity of the TGN 1412 trial disaster cytokine storm correlated with IL‐2 release (2013) · cites this paper as [37]
In the citing paper
“Since Tconvs can also upregulate CD25 and FOXP3, and downregulate CD127 [380, 386], it is critical to set gates for all of these markers on resting populations of T cells, typically using blood cells from healthy individuals.”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [386]
Citations
Cites
Control of Regulatory T Cell Development by the Transcription Factor Foxp3
Hori, S., Nomura, T., & Sakaguchi, S. (2003) · Science · doi:10.1126/science.1079490 · Cited by 8,187
Foxp3 programs the development and function of CD4+CD25+ regulatory T cells
Fontenot, J. D., Gavin, M. A., & Rudensky, A. Y. (2003) · Nature Immunology · doi:10.1038/ni904 · Cited by 7,745
Park, J.-H., Adoro, S., Guinter, T., Erman, B., Alag, A. S., Catalfamo, M., Kimura, M. Y., Cui, Y., Lucas, P. J., Gress, R. E., et al. (2010) · Nature Immunology · doi:10.1038/ni.1840 · Cited by 5,835
Sakaguchi, S., Sakaguchi, N., Asano, M., Itoh, M., & Toda, M. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.155.3.1151 · Cited by 5,608
Bennett, C. L., Christie, J., Ramsdell, F., Brunkow, M. E., Ferguson, P. J., Whitesell, L., Kelly, T. E., Saulsbury, F. T., Chance, P. F., & Ochs, H. D. (2001) · Nature Genetics · doi:10.1038/83713 · Cited by 3,402
Sakaguchi, S. (2005) · Nature Immunology · doi:10.1038/ni1178 · Cited by 2,669
Brunkow, M. E., Jeffery, E. W., Hjerrild, K. A., Paeper, B., Clark, L. B., Yasayko, S.-A., Wilkinson, J. E., Galas, D., Ziegler, S. F., & Ramsdell, F. (2001) · Nature Genetics · doi:10.1038/83784 · Cited by 2,636
Regulatory T Cell Lineage Specification by the Forkhead Transcription Factor Foxp3
Fontenot, J. D., Rasmussen, J. P., Williams, L. M., Dooley, J. L., Farr, A. G., & Rudensky, A. Y. (2005) · Immunity · doi:10.1016/j.immuni.2005.01.016 · Cited by 2,279
Wildin, R. S., Ramsdell, F., Peake, J., Faravelli, F., Casanova, J.-L., Buist, N., Levy-Lahad, E., Mazzella, M., Goulet, O., Perroni, L., et al. (2001) · Nature Genetics · doi:10.1038/83707 · Cited by 1,922
Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation.
Asano, M., Toda, M., Sakaguchi, N., & Sakaguchi, S. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.2.387 · Cited by 1,330
Cited by
Items 501–600 of 1,000
Regulatory T Cells in the Tumor Microenvironment
Dadey, R., Workman, C. J., & Vignali, D. A. A. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-49270-0_6 · Cited by 34
Role of CD4+CD25+FOXP3+TRegcells on tumor immunity
Hariyanto, A. D., Permata, T. B. M., & Gondhowiardjo, S. A. (2021) · Immunological Medicine · doi:10.1080/25785826.2021.1975228 · Cited by 35
Panfilis, G. D., Campanini, N., Santini, M., Mori, G., Tognetti, E., Maestri, R., Lombardi, M., Froio, E., Ferrari, D., & Ricci, R. (2007) · Journal of Investigative Dermatology · doi:10.1038/sj.jid.5701046 · Cited by 30
“, 2007), and down-modulates responses to TCR-mediated stimulation (Wang et al., 2007; Ziegler, 2007).”
Epigenetic Modification of the FoxP3 TSDR in HAM/TSP Decreases the Functional Suppression of Tregs
Anderson, M. R., Enose‐Akahata, Y., Massoud, R., Ngouth, N., Tanaka, Y., Oh, U., & Jacobson, S. (2014) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-014-9547-z · Cited by 31
“Additionally, there is up-regulation of FoxP3 transiently upon activation of T cells (Wang et al. 2007).”
InfluentialMonitoring T cell alloreactivity
Mehrotra, A., Leventhal, J. S., Purroy, C., & Cravedi, P. (2014) · Transplantation Reviews · doi:10.1016/j.trre.2014.11.001 · Cited by 30
“numbers of FoxP3+ Tregs and tolerance [67], the induction of CD25 and FoxP3 upon activation of human Teffs has led to far more variable clinical data [68].”
BackgroundMesquita, D., Cruvinel, W. D. M., Araújo, J. A. P., Pucci, F. V. C., Salmazi, K. C., Kallás, E., & Andrade, L. E. C. (2010) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2010.489229 · Cited by 30
Association of two clones allows for optimal detection of human FOXP3
Presicce, P., Moreno‐Fernandez, M. E., Lages, C. S., Orsborn, K. I., & Chougnet, C. A. (2010) · Cytometry Part A · doi:10.1002/cyto.a.20875 · Cited by 29
T cells with regulatory activity in hepatitis C virus infection: what we know and what we don’t
Dolganiuc, A., & Szabó, G. (2008) · Journal of Leukocyte Biology · doi:10.1189/jlb.1107770 · Cited by 31
“However, this may prove to be a challenging task, as the current literature indicates that in humans, the majority of activated T cell subsets is CD25 and can at least transiently express FoxP3 [47].”
BackgroundThe FOXP3+ subset of human CD4+CD8+ thymocytes is immature and subject to intrathymic selection
Tuovinen, H., Pekkarinen, P. T., Rossi, L. H., Mattila, I. P., & Arstila, T. P. (2008) · Immunology and Cell Biology · doi:10.1038/icb.2008.36 · Cited by 30
CD25 high T Cells with a Prolonged Survival Inhibit Development of Diabetes
Yan, Y., Xiong, Z., Zhang, S., Song, J. T., Huang, Y., Thornton, A. M., Wang, H., & Yang, X.-F. (2008) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200802100401 · Cited by 30
Cutting Edge: Human CD4−CD8− Thymocytes Express FOXP3 in the Absence of a TCR
Tuovinen, H., Kekäläinen, E., Rossi, L. H., Puntila, J., & Arstila, T. P. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.6.3651 · Cited by 30
Next steps in regulatory T cells: Biology and clinical application
Zou, C., Li, P., Li, B., Sparwasser, T. D., & Yuan, J. (2026) · Cell · doi:10.1016/j.cell.2025.11.035 · Cited by 35
Hamza, E., Gerber, V., Steinbach, F., & Marti, E. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03489.x · Cited by 29
Bohana‐Kashtan, O., Morisot, S., Hildreth, R. L., Brayton, C. F., Levitsky, H. I., & Civin, C. I. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800561 · Cited by 29
Baatjes, A. J., Smith, S. G., WATSON, R. M., Howie, K. J., Murphy, D. M., Larché, M., Denburg, J. A., Inman, M. D., & O’Byrne, P. M. (2015) · Clinical & Experimental Allergy · doi:10.1111/cea.12594 · Cited by 29
Role of Tregs in Cancer Dormancy or Recurrence
Manjili, M. H., & Butler, S. E. (2016) · Immunological Investigations · doi:10.1080/08820139.2016.1194428 · Cited by 29
“T cells without conferring a regulatory function (Kmieciak et al. 2009; Wang et al. 2007).”
Hedreul, M. T., Gillett, A., Olsson, T. P., Jagodic, M., & Harris, R. A. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.02.010 · Cited by 31
“Alternatively, higher CD25 and Foxp3 cells could reflect more activated Tcells in the susceptible strain (Cantrell and Smith,1984; Wang et al., 2007).”
BackgroundChera, M., Hamel, Y., Baillou, C., Touil, S., Guillot‐Delost, M., Charlotte, F., Kossir, L., Simonin, G., Maury, S., Cohen, J. L., et al. (2014) · Cell Transplantation · doi:10.3727/096368914x683566 · Cited by 28
“It is also known that activated human Teffs express FOXP3 (2,48,59).”
BackgroundT regulatory cells in B‐cell malignancy – tumour support or kiss of death?
Lindqvist, C. A., & Loskog, A. (2011) · Immunology · doi:10.1111/j.1365-2567.2011.03539.x · Cited by 35
Åkesson, K., Tompa, A., Rydén, A., & Faresjö, M. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12559 · Cited by 31
Regulatory T cells for the prevention of graft‐versus‐host disease: Professionals defeat amateurs
Edinger, M. (2009) · European Journal of Immunology · doi:10.1002/eji.200940030 · Cited by 28
Guichelaar, T., Emmelot, M. E., Rozemuller, H., Martini, B., Groen, R. W. J., Storm, G., Lokhorst, H. M., Martens, A. C., & Mutis, T. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2177 · Cited by 28
Rossato, C., Brandão, W. N., de Castro, S. B. R., de Almeida, D. C., Maranduba, C. M. C., Câmara, N. O. S., Peron, J. P. S., & Silva, F. D. S. (2017) · Biologicals · doi:10.1016/j.biologicals.2017.06.007 · Cited by 30
Epigenetic dynamics during CD4+ T cells lineage commitment
Rodríguez, R. M. A., López‐Larrea, C., & Suárez-Álvarez, B. (2015) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2015.04.020 · Cited by 32
Michaëlsson, J., Barbosa, H. M. R., Jordan, K. A., Chapman, J. M., Brunialti, M. K. C., Neto, W. K., Nukui, Y., Sabino, É. C., Chieia, M. A. T., Oliveira, A. S. B., et al. (2008) · BMC Immunology · doi:10.1186/1471-2172-9-41 · Cited by 34
“a fortuitous event, as recent reports suggest that FOXP3 is also expressed on non regulatory T cells in humans [46, 47 ].”
ResultPiconese, S., & Colombo, M. P. (2007) · Springer eBooks · doi:10.1007/978-0-387-69118-3_4 · Cited by 29
“T cells in humans (Wang et al., 2007) and the very last identified unique signature distinguishing Treg is the downregulation of cyclic nucleotide phosphodiesterase”
BackgroundGascoyne, D. M., Spearman, H., Lyne, L., Puliyadi, R., Perez‐Alcantara, M., Coulton, L. A., Fisher, S. E., Croucher, P. I., & Banham, A. H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0128513 · Cited by 28
“This is also observed for other family members, for example transient FOXP3 induction in activated human T-cells[49] in contrast to maintained FOXP3 expression in regulatory T-cell populations.”
BackgroundAltered regulatory T cell phenotype in latent autoimmune diabetes of the adults (LADA)
Radenkovic, M., Silver, C., Arvastsson, J., Lynch, K. F., Lernmark, Å., Harris, R. A., Agardh, C., & Cilio, C. (2016) · Clinical & Experimental Immunology · doi:10.1111/cei.12834 · Cited by 29
Overgaard, N. H., Principe, D. R., Schachtschneider, K. M., Jakobsen, J. T., Rund, L. A., Grippo, P. J., Schook, L. B., & Jungersen, G. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01301 · Cited by 29
“Recent findings suggest that human T helper cells can transiently upregulate FOXP3 upon activation, although only the T cells stably expressing FOXP3 were found to exhibit a suppressive nature (71).”
BackgroundOu, K., Hamo, D., Schulze, A. S., Roemhild, A., Kaiser, D., Gasparoni, G., Salhab, A., Zarrinrad, G., Amini, L., Schlickeiser, S., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.751590 · Cited by 25
“In addition, classical Treg biomarkers (e.g., FOXP3, CD25, and lack of CD127 expression) can also be found on contaminating activated pro-inflammatory conventional T cells (Tran et al., 2007; Wang et al., 2007; Kmieciak et al., 2009).”
BackgroundRichert-Spuhler, L. E., & Lund, J. M. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.07.015 · Cited by 28
Expansion of Allospecific Regulatory T Cells After Anergized, Mismatched Bone Marrow Transplantation
DAVIES, J. K., Nadler, L. M., & Guinan, E. C. (2009) · Science Translational Medicine · doi:10.1126/scitranslmed.3000153 · Cited by 27
Govindaraj, C., Scalzo‐Inguanti, K., Scholzen, A., Li, S., & Plebanski, M. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00233 · Cited by 28
“FOXP3 expression on activated effector T cells has however been reported to be transient and relatively low when compared to Tregs (9).”
Avoiding Immunological Rejection in Regenerative Medicine
Bolton, E. M., & Bradley, J. A. (2015) · Regenerative Medicine · doi:10.2217/rme.15.11 · Cited by 27
Li, Z., Vermeire, S., Bullens, D. M. A., Ferrante, M., Steen, K. V., Noman, M., Rutgeerts, P. J., Ceuppens, J. L., & Assche, G. V. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000509 · Cited by 32
Potential T regulatory cell therapy in transplantation: how far have we come and how far can we go?
Battaglia, M. (2010) · Transplant International · doi:10.1111/j.1432-2277.2010.01127.x · Cited by 30
“For instance, FOXP3 expression, which is constitutively high in nTreg cells, can be up-regulated in non-Treg cells upon activation [14,15].”
BackgroundNegative Feedback Regulation of T Cells via Interleukin-2 and FOXP3 Reciprocity
Popmihajlov, Z., & Smith, K. A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0001581 · Cited by 27
“Moreover, human CD8+ T cells were also found to express FOXP3 mRNA [31,32].”
BackgroundGeneration and Immune Regulation of CD4+CD25-Foxp3) T Cells in Chronic Obstructive Pulmonary Disease
Wu, J.-H., Zhou, M., Jin, Y., Meng, Z.-J., Xiong, X.-Z., Sun, S.-W., Miao, S.-Y., Han, H.-L., & Tao, X.-N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00220 · Cited by 26
“Having established that TCR stimulation alone can induce CD25 and Foxp3 expression in human CD4CD25 T cells (9, 10), we also observed that CD4CD25Foxp3 T cells (>85%) were induced when naïve CD4 T cells were activated through TCR stimulation independent of exogenous TGFβ1 (Figure 2A); moreover, TGFβ1 stimulation did n…”
BackgroundResultFoxall, R. B., Albuquerque, A. S., Soares, R. S., Baptista, A. P., Cavaleiro, R., Rego, R. T., Gómes, P., Victorino, R. M. M., & Sousa, A. E. (2011) · AIDS · doi:10.1097/qad.0b013e32834b3554 · Cited by 26
“Although initially described as a highly specific Treg lineage marker, Foxp3 has increasingly been shown to be transitorily upregulated upon T-cell receptor stimulation of human CD4þ T cells [34,35].”
BackgroundRegulatory T Cells and Transplantation Tolerance
Hilbrands, R., Howie, D., Cobbold, S. P., & Waldmann, H. (2013) · Immunotherapy · doi:10.2217/imt.13.69 · Cited by 26
SOCS1 and Regulation of Regulatory T Cells Plasticity
Takahashi, R., & Yoshimura, A. (2014) · Journal of Immunology Research · doi:10.1155/2014/943149 · Cited by 28
CD4+CD25-FoxP3+T cells: a distinct subset or a heterogeneous population?
Zohouri, M., Mehdipour, F., Razmkhah, M., Faghih, Z. S., & Ghaderi, A. A. (2020) · International Reviews of Immunology · doi:10.1080/08830185.2020.1797005 · Cited by 27
“This T cell subset produces more IL-2, IFN-c and TNF-a than Tregs, but less than effector T cells.(5,8,43,53,73) They also produce IL-10 and TGFb.”
BackgroundSignificance of regulatory T cells in cancer immunology and immunotherapy
Sugiyama, D., Hinohara, K., & Nishikawa, H. (2022) · Experimental Dermatology · doi:10.1111/exd.14721 · Cited by 27
Fujii, H., Arakawa, A., Kitoh, A., Miyara, M., Kato, M. K., KORE-EDA, S., Sakaguchi, S., Miyachi, Y., Tanioka, M., & Ono, M. (2010) · British Journal of Dermatology · doi:10.1111/j.1365-2133.2010.10199.x · Cited by 28
Wang, J., van Dongen, H., Scherer, H. U., Huizinga, T. W. J., & Toes, R. E. M. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23460 · Cited by 28
“Fluorescence-activated cell-sorted CD4+,CD25responder T cells (Resp), membrane-bound TNFα-negative CD4+,CD25++ T cells (mTNF-), and membrane-bound TNFα-positive CD4+,CD25++ T cells (mTNF+) (1 × 104 cells/well) were activated with phytohemagglutinin (1 µg/ml) and feeders (5 × 104 cells/well) in the absence or presence…”
BackgroundSelf-citationFOXP3 and GARP (LRRC32): the master and its minion
Probst‐Kepper, M., & Buer, J. (2010) · Biology Direct · doi:10.1186/1745-6150-5-8 · Cited by 27
Dendritic cell–regulatory T‐cell interactions control self‐directed immunity
Lange, C. M., Dürr, M., Doster, H., Melms, A., & Bischof, F. (2007) · Immunology and Cell Biology · doi:10.1038/sj.icb.7100088 · Cited by 31
Guillot‐Delost, M., Cheraï, M., Hamel, Y., Rosenzwajg, M., Baillou, C., Simonin, G., Leclercq, V., Mariotti‐Ferrandiz, E., Six, A., Bon‐Durand, V., et al. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1220 · Cited by 26
Biomarkers of Transplantation Tolerance: More Hopeful than Helpful?
Cobbold, S. P., Adams, E., & Waldmann, H. (2011) · Frontiers in Immunology · doi:10.3389/fimmu.2011.00009 · Cited by 27
“One reason for this might be that foxp3 can be transiently expressed in activated effector T cells (Wang et al., 2007).”
BackgroundHamza, E., Akdiş, C. A., Wagner, B., Steinbach, F., & Marti, E. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12131 · Cited by 26
Sun, J., Tang, D. N., Fu, T., & Sharma, P. (2011) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0236 · Cited by 29
“Furthermore, although stable high expression of FoxP3 is restricted to Treg cells in both mice and humans, it has been shown in humans (but not in mice) that FoxP3 expression can be induced after the stimulation of conventional T cells (8, 9), thereby making it difficult to distinguish Tregs from activated effector T…”
BackgroundResultInfluentialSchmidt, A., Éliás, S., Joshi, R. N., & Tegner, J. N. (2016) · Journal of Visualized Experiments · doi:10.3791/55015 · Cited by 52
Ward‐Hartstonge, K. A., McCall, J. L., McCulloch, T. R., Kamps, A.-K., Girardin, A., Cretney, E., Munro, F. M., & Kemp, R. A. (2017) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-016-1951-1 · Cited by 28
“FOXP3 is often used as a marker of Tregs, despite transient upregulation on activated T cells [11] and lack of expression in some regulatory subsets.”
BackgroundT-cell regulation in Erythema Nodosum Leprosum
Negera, E., Walker, S. L., Bobosha, K., Howe, R., Aseffa, A., Dockrell, H. M., & Lockwood, D. N. J. (2017) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0006001 · Cited by 29
“Although transient FoxP3 expression in ex-vivo activated human T-cells has been reported [57], it remains as a good marker for Tregs.”
BackgroundStability of Regulatory T-cell Lineage
Hori, S. (2011) · Advances in immunology · doi:10.1016/b978-0-12-387827-4.00001-2 · Cited by 34
Transcriptional Control of Regulatory T-Cell Differentiation
van der Veeken, J., Arvey, A. J., & Rudensky, A. Y. (2013) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2013.78.020289 · Cited by 25
“Similarly, human CD4 T cells transiently express low levels of Foxp3 following TCR stimulation, while maintaining CNS2 in a methylated state (Gavin et al. 2006; Allan et al. 2007; Tran et al. 2007; Wang et al. 2007; Nagar et al. 2008).”
BackgroundKindlund, B., Sjöling, Å., Hansson, M., Edebo, A., Hansson, L., Sjövall, H., Svennerholm, A., & Lundin, B. S. (2009) · Helicobacter · doi:10.1111/j.1523-5378.2009.00673.x · Cited by 28
Ye, L., GOODALL, J. C., Zhang, L., Putintseva, E. V., Lam, B., Jiang, L., Liu, W., Yin, J., Lin, L., Li, T., et al. (2015) · Immunology and Cell Biology · doi:10.1038/icb.2015.90 · Cited by 29
Molecular Markers Distinguishing T Cell Subtypes With TSDR Strand-Bias Methylation
Minskaia, E., Saraiva, B. C., Soares, M. V. D., Azevedo, R. I., Ribeiro, R. M., Kumar, S., Vieira, A. I. S., & de Lacerda, J. F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02540 · Cited by 28
“(B) Methylation pattern of the FOXP3 enhancer in five cell populations: CD34+ (1), CD45RA+CD15s− (2), CD45RA−CD15s− (3), CD45RA−CD15s+ (4), and Tcon (5), of representative donor M4.”
BackgroundInfluentialLi, X., Wu, D., Liu, Y., Zhang, S., Tian, F.-L., Sun, Q., Wei, W., Cao, X., & Jia, L. (2021) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2021.112987 · Cited by 26
Blake, M. K., O’Connell, P. M., & Aldhamen, Y. A. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1082195 · Cited by 29
“Together, these findings suggest that TOX can be transiently expressed in CD8+T cells without committing them towards exhaustion, in a manner analogous to FOXP3 which is also transiently upregulated during CD4 T cell TCR stimulation (Wang et al., 2007).”
BackgroundMorina, L., Jones, M., Oguz, C., Kaplan, M. J., Gangaplara, A., Fitzhugh, C. D., Kanakry, C. G., Shevach, E. M., & Buszko, M. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1114780 · Cited by 27
Scottà, C., Soligo, M., Camperio, C., & Piccolella, E. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1025 · Cited by 25
“This suggests that after CD28 signaling CD4 FOXP3 T cells predominantly arose from CD4 FOXP3 T cells, although with levels of FOXP3 comparable to that observed in CD4 CD25 T cells lacking Treg function (27).”
BackgroundLi, G., Abediankenari, S., Kim, Y., Campbell, T., Ito, S., Graham-Evans, B. E., Cooper, S. H., & Broxmeyer, H. E. (2007) · Blood · doi:10.1182/blood-2006-10-050583 · Cited by 25
Yan, B., & Liu, Y. (2009) · The Open Rheumatology Journal · doi:10.2174/1874312900903010022 · Cited by 25
“Although transient up-regulation of Foxp3 expression has been observed in human T cells upon activation, conflicting data have also been published concerning the suppressive capacity of T cells with transient Foxp3 expression [7-9].”
BackgroundNo association between vitamin D and β‐cell autoimmunity in Finnish and Estonian children
Reinert‐Hartwall, L., Honkanen, J. K., Härkönen, T., Ilonen, J., Simell, O., Peet, A., Tillmann, V., Lamberg-Allardt, C. J. E., Virtanen, S. M., Knip, M., et al. (2014) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2550 · Cited by 29
“In humans, T-cell activation results in the up-regulation of FOXP3 as well in effector T cells, in which this response is important for the inhibition of T-cell activation [40,41].”
BackgroundFOXP3+regulatory T cells as biomarkers in human malignancies
Bignone, P. A., & Banham, A. H. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712590802494022 · Cited by 26
“The literature concerning whether FOXP3 constitutes a bona fide marker for human regulatory T cells is comprehensively discussed in [26-31] and also in a recent review by Roncarolo and Gregori [5] and thus there is no need to duplicate their efforts here.”
BackgroundFunctional and genomic analyses of FOXP3-transduced Jurkat-T cells as regulatory T (Treg)-like cells
Kim, J., Kim, H., Hurt, E. M., Chen, X., Howard, O. M. Z., & Farrar, W. L. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.07.187 · Cited by 25
Arsenic trioxide is an immune adjuvant in liver cancer treatment
Wang, L., Wang, R., Fan, L., Liang, W., Liang, K., Xu, Y., Peng, G., & Ye, Q. (2016) · Molecular Immunology · doi:10.1016/j.molimm.2016.12.001 · Cited by 25
Baroja‐Mazo, A., Revilla‐Nuin, B., de Bejar, Á., Martínez-Alarcón, L., Herrero, J. I., El‐Tayeb, A., Müller, C. E., Aparício, P., Pelegrín, P., & Pons, J. A. (2018) · American Journal of Transplantation · doi:10.1111/ajt.15023 · Cited by 26
Depleting T regulatory cells by targeting intracellular Foxp3 with a TCR mimic antibody
Dao, T., Mun, S. S., Scott, A., Jarvis, C. A., Korontsvit, T., Yang, Z., Liu, L., Klatt, M. G., Guerreiro, M., Selvakumar, A., et al. (2019) · OncoImmunology · doi:10.1080/2162402x.2019.1570778 · Cited by 26
Induction of antigen-specific human T suppressor cells by membrane and soluble ILT3
Vlad, G., & Suciu‐Foca, N. (2012) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2012.09.011 · Cited by 27
Regulatory T cells—the renaissance of the suppressor T cells
Bopp, T., Jonuleit, H., & Schmitt, E. (2007) · Annals of Medicine · doi:10.1080/07853890701379700 · Cited by 33
Editorial: Quality or quantity? Unraveling the role of Treg cells in rheumatoid arthritis
Prakken, B. J., Wehrens, E. J., & van Wijk, F. (2012) · Arthritis & Rheumatism · doi:10.1002/art.37831 · Cited by 27
Figliuolo, V. R., Jamwal, D. R., & Kiela, P. R. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-6407-9_9 · Cited by 28
Stachtea, X., Loughrey, M. B., Salvucci, M., Lindner, A. U., Cho, S., McDonough, E., Sood, A., Graf, J. F., Santamaría-Pang, A., Corwin, A. D., et al. (2021) · Modern Pathology · doi:10.1038/s41379-021-00953-0 · Cited by 25
Neuroinflammation: Extinguishing a blaze of T cells
Benallegue, N., Kébir, H., & Alvarez, J. I. (2022) · Immunological Reviews · doi:10.1111/imr.13122 · Cited by 26
Regulatory T Cells in Autoimmune and Viral Chronic Hepatitis
Lapierre, P., & Lamarre, A. (2015) · Journal of Immunology Research · doi:10.1155/2015/479703 · Cited by 28
“on markers like CD25 and FOXP3 which can be transiently expressed by activated effector T cells [43].”
BackgroundHanschen, M., Tajima, G., O’Leary, F., Hoang, K. B., Ikeda, K., & Lederer, J. A. (2011) · Journal of Immunological Methods · doi:10.1016/j.jim.2011.08.023 · Cited by 24
“In addition, we knew that we would have to use a cell-based approach because it would not be possible to purify Tregs from non-Treg CD4+ T cells rapidly and effectively enough to accurately detect early signaling responses (Gavin et al., 2006; Wang et al., 2007).”
MethodMittag, D., Scholzen, A., Varese, N. P., Baxter, L., Paukovics, G., Harrison, L. C., Rolland, J. M., & O’Hehir, R. E. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0901036 · Cited by 24
“Previous studies on the regulatory function and stability of activation-induced Foxp3 expression in human CD4CD25(2) cells are conflicting, demonstrating either an association (15, 16, 23) or no association (12, 24, 25) between induced Foxp3 expression and suppressor function.”
BackgroundResultGlišić, S., Ehlenbach, S. J., Jailwala, P., Waukau, J., Jana, S., & Ghosh, S. (2010) · Cell and Tissue Research · doi:10.1007/s00441-009-0900-0 · Cited by 24
“As some reports indicate that Foxp3 after activation is transient in nature in humans (Wang et al. 2007b), we have based our conclusions more on functional differences, since cells with activation-induced Foxp3 expression in human T effector cells have been reported not to suppress proliferation…”
BackgroundResultVolchenkov, R., Brun, J. G., Jonsson, R., & Appel, S. (2013) · Arthritis Research & Therapy · doi:10.1186/ar4294 · Cited by 24
Riou, C., Strickland, N., Soares, A. P., Corleis, B., Kwon, D. S., Wherry, E. J., Wilkinson, R. J., & Burgers, W. A. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1502094 · Cited by 26
“In this context, Foxp3 upregulation has been associated with hyporesponsiveness of activated T cells, but was not directly correlated with their suppressive capabilities (51).”
BackgroundT lymphocyte trafficking: molecules and mechanisms
Marelli‐Berg, F. M. (2012) · Frontiers in bioscience · doi:10.2741/4111 · Cited by 32
“It must also be considered that high levels of CD25 and FoxP3 are transiently expressed by recently activated human T cells, which do not display suppressor functions (168, 169).”
Impact of In Utero Exposure to Malaria on Fetal T Cell Immunity
Odorizzi, P. M., & Feeney, M. E. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.08.005 · Cited by 27
“This is problematic, as both CD25 and FoxP3 can be transiently upregulated by activated CD4+ T cells [92,93].”
BackgroundBlokland, S. L. M., van Vliet-Moret, F. M., Hillen, M. R., Pandit, A., Goldschmeding, R., Kruize, A. A., Bouma, G., van Maurik, A., Olek, S., Hoffmüller, U., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/kez268 · Cited by 28
Mitchell, J. M., Kelly, J., Kvedaraite, E., Greenwood, T. V. B., Henter, J., Pellicci, D. G., Berzins, S. P., & Kannourakis, G. (2020) · Clinical Immunology · doi:10.1016/j.clim.2020.108418 · Cited by 24
Human CD4low CD25high regulatory T cells indiscriminately kill autologous activated T cells
Bryl, E., Daca, A., Jóźwik, A., & Witkowski, J. M. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02961.x · Cited by 24
Boosting BCG vaccination with MVA85A down-regulates the immunoregulatory cytokine TGF-β1
Fletcher, H. A., Pathan, A. A., Berthoud, T. K., Dunachie, S. J., Whelan, K. T., Alder, N. C., Sander, C. R., Hill, A. V. S., & McShane, H. (2008) · Vaccine · doi:10.1016/j.vaccine.2008.07.040 · Cited by 24
“It is known that FoxP3 mRNA is transiently expressed by T cells upon activation and that this does not commit cells to a regulatory phenotype [24].”
BackgroundKlapa, S., Mueller, A., Csernok, E., Fagin, U., Klenerman, P., Holl‐Ulrich, K., Gross, W. L., & Lamprecht, P. (2010) · PubMed · Cited by 24
Zhang, X., Greve, P. F., Minh, T. T. N., Wubbolts, R., Demir, A. Y., Zaal, E. A., Berkers, C. R., Boes, M. L., & Stoorvogel, W. (2024) · Journal of Extracellular Vesicles · doi:10.1002/jev2.12457 · Cited by 24
Effects of Salvia officinalis L. extract on experimental acute inflammation.
Oniga, I., Pârvu, A. E., Toiu, A., & Benedec, D. (2007) · PubMed · Cited by 23
Freier, C. P., Kühn, C., Rapp, M., Endres, S., Mayr, D. C., Friese, K., Anz, D., & Jeschke, U. (2015) · American Journal of Reproductive Immunology · doi:10.1111/aji.12399 · Cited by 22
Sahin, M. A., Şahın, E., & Köksoy, S. (2013) · Human Immunology · doi:10.1016/j.humimm.2013.05.009 · Cited by 23
Mo, Y., Yue, M., Yim, L. Y., Zhou, R., Yu, C., Peng, Q., Zhou, Y., Luk, T., Lui, G. C.-Y., Huang, H., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104877 · Cited by 25
Self-citationHomeostatic expansion as a barrier to lymphocyte depletion strategies
Zwang, N. A., & Turka, L. A. (2014) · Current Opinion in Organ Transplantation · doi:10.1097/mot.0000000000000096 · Cited by 24
Noyan, F., Lee, Y.-S., Hardtke‐Wolenski, M., Knoefel, A.-K., Taubert, R., Baron, U., Manns, M. P., & Jaeckel, E. (2013) · Transplantation Proceedings · doi:10.1016/j.transproceed.2013.01.073 · Cited by 23
Identification of a human Th1-like IFNγ-secreting Treg subtype deriving from effector T cells
Venigalla, R. K., Guttikonda, P. J., Eckstein, V., Ho, A. D., Sertel, S., Lorenz, H., & Tretter, T. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.06.004 · Cited by 31
Hughson, A. L., Bromberg, I., Johnson, B. D., Quataert, S. A., Jospe, N., & Fowell, D. J. (2011) · Diabetes · doi:10.2337/db10-1661 · Cited by 23
Vanderlocht, J., van Elssen, C. H. M. J., Senden-Gijsbers, B. L. M. G., Meek, B., Cloosen, S., Libon, C., Bos, G. M. J., & Germeraad, W. T. V. (2010) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463201002300104 · Cited by 23
Metadata
- Authors
- Wang, J., Ioan‐Facsinay, A., van der Voort, E. I. H., Huizinga, T. W. J., & Toes, R. E. M.
- Affiliations
- Leiden University Medical Center (NL)
- Corresponding author
- Toes, René E. M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 2006-12-21
- Volume
- 37
- Issue
- 1
- Pages
- 129-138
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1984909066
- Cited by
- 1,011
- References
- 43
- Citations by year
- 2026: 22 · 2025: 23 · 2024: 24 · 2023: 29 · 2022: 25 · 2021: 36 · 2020: 39 · 2019: 34 · 2018: 41 · 2017: 36 · 2016: 43 · 2015: 47 · 2014: 61 · 2013: 63 · 2012: 69
- FWCI
- 31.41
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Journal of Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- Foxp3, regulatory T cells, CD4+ T cell activation, T cell hyporesponsiveness, CD25, anti-CD3 stimulation, human T cells
- MeSH terms
- Cells, Cultured, Humans, Lymphocyte Activation, Time Factors, CD4-Positive T-Lymphocytes, T-Lymphocyte Subsets, Resting Phase, Cell Cycle, Cytokines, Self Tolerance, Coculture Techniques, Cell Proliferation, T-Lymphocytes, Regulatory, Forkhead Transcription Factors, Interleukin-2 Receptor alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.